Inventor
GILBERT MARK J
US19 patents
⚠️ This page may combine multiple inventors who share the name “GILBERT MARK J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ILLINOIS
8 patentsUS9592229B2Mar 14, 2017
Potent anticancer activity via dual compound activation
UNIV ILLINOIS8 citations83
US10888560B2Jan 12, 2021
Procaspase 3 activation by combination therapy
UNIV ILLINOIS1 citations72
US10874666B2Dec 29, 2020
Procaspase combination therapy for glioblastoma
UNIV ILLINOIS1 citations71
US12433885B2Oct 7, 2025
Procaspase combination therapy for glioblastoma
UNIV ILLINOIS0 citations61
US11844798B2Dec 19, 2023
Procaspase combination therapy for glioblastoma
UNIV ILLINOIS0 citations61
US11833147B2Dec 5, 2023
Procaspase 3 activation by combination therapy
UNIV ILLINOIS0 citations61
US10085978B2Oct 2, 2018
Procaspase combination therapy for glioblastoma
UNIV ILLINOIS1 citations61
US10085977B2Oct 2, 2018
Procaspase 3 activation by combination therapy
UNIV ILLINOIS1 citations61
JUNO THERAPEUTICS INC
7 patentsUS10507219B2Dec 17, 2019
Methods and compositions for dosing in adoptive cell therapy
JUNO THERAPEUTICS INC10 citations83
US11944647B2Apr 2, 2024
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC5 citations82
US11413310B2Aug 16, 2022
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC12 citations82
US11266739B2Mar 8, 2022
Methods and compositions for adoptive cell therapy
JUNO THERAPEUTICS INC2 citations72
US11815514B2Nov 14, 2023
Methods and compositions related to toxicity associated with cell therapy
JUNO THERAPEUTICS INC2 citations71
US11633426B2Apr 25, 2023
Methods and compositions for dosing in adoptive cell therapy
JUNO THERAPEUTICS INC1 citations62
US12583904B2Mar 24, 2026
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC0 citations59